Whereas drug traffickers are mass-producing fake or counterfeit pills and falsely marketing them as legitimate prescription pills to deceive the people of the United States; Whereas many fake or counterfeit pills are made to look like prescription name-brand opioids, stimulants, or anxiety medications; Whereas drug traffickers are using fake or counterfeit pills to exploit the opioid crisis and prescription drug misuse; Whereas the Drug Enforcement Administration (referred to in this preamble as the DEA ) has observed a dramatic rise in the number of counterfeit pills containing not less than 2 milligrams of fentanyl, which is considered a deadly dose; Whereas 6 out of every 10 pills with fentanyl tested by the DEA contain a potentially lethal dose; Whereas counterfeit pills may also contain fentanyl-related substances and methamphetamine; Whereas the number of counterfeit pills with fentanyl seized by law enforcement agencies has increased by nearly 502 percent since 2019; Whereas more than 50,000,000 counterfeit pills were seized within the last year, which represents 379,000,000 doses of illicit fentanyl. Whereas fake or counterfeit pills have been identified in all 50 States and the District of Columbia; Whereas illicit fentanyl has also been detected in illicit drugs such as heroin, cocaine, and MDMA. Whereas, for the 12-month period ending in September 2022, more than 106,000 individuals in the United States died of drug-induced deaths, and 72,000 of those deaths involved illicit fentanyl and other synthetic opioids; Whereas, over the last 20 years, drug-induced deaths among individuals 15 to 35 years of age have increased 6-fold, largely driven by the increase in illicit fentanyl drugs; Whereas, for the 12-month period ending in June 2022, illicit fentanyl was involved in more deaths of individuals under 50 years of age than any single other cause; Whereas fake counterfeit pills are easily accessible and often sold on social media and e-commerce platforms, making them accessible to teens and youth